Advanced Prostate Cancer
4,529 members4,372 posts

Trials NCT 03338790 or NCT02897375 Decided on NCT 03338790 trial

Just an update decided to do NCT 03338790 with Nivolumab and Rucaparib, study closer to me, less travel and parp inhibitor may help . Anyone on either of this trials NCT 03338790 (An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CheckMate 9KD))

or NCT02897375 (Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors)

Thanks

You may also like...